79 related articles for article (PubMed ID: 1944157)
1. [The growth rate as a parameter of degree of biological malignancy and prediction of metastasis by tumor marker doubling and half time].
Takahashi Y; Mai M; Kasama S
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1074-7. PubMed ID: 1944157
[TBL] [Abstract][Full Text] [Related]
2. [Chronology of recurrent gastric cancer].
Takahashi Y; Mai M; Ogino T; Ueda H; Ueno M; Kusama S
Nihon Geka Gakkai Zasshi; 1986 Jun; 87(6):604-7. PubMed ID: 2426566
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study on biological difference between gastric cancer and colorectal cancer].
Mai M; Ohta T; Minamoto T; Takahashi Y
Nihon Geka Gakkai Zasshi; 1996 Apr; 97(4):263-8. PubMed ID: 8692141
[TBL] [Abstract][Full Text] [Related]
4. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
5. [Study of CEA doubling time in liver metastasis from colonic cancer and postoperative survival time].
Takahashi Y; Kusama S; Mai M; Ueno M; Ogino T; Ueda H; Sawaguchi K
Nihon Geka Gakkai Zasshi; 1986 Nov; 87(11):1422-5. PubMed ID: 3785131
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
7. [Indices of the malignancy of cancer--is it possible to predict the recurrence or metastasis of cancer?].
Tobe T
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1062-5. PubMed ID: 1944154
[TBL] [Abstract][Full Text] [Related]
8. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Mimori K; Fukagawa T; Kosaka Y; Ishikawa K; Iwatsuki M; Yokobori T; Hirasaki S; Takatsuno Y; Sakashita H; Ishii H; Sasako M; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2934-42. PubMed ID: 18661187
[TBL] [Abstract][Full Text] [Related]
9. [Gastrointestinal cancer].
Takahashi Y
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
[TBL] [Abstract][Full Text] [Related]
10. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
11. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
12. [The correlation between the reduction rate of tumor and the survival time of patients as an effect of chemotherapy].
Takahashi Y; Kusama S; Mai M
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):641-5. PubMed ID: 3412298
[TBL] [Abstract][Full Text] [Related]
13. [Tumor markers--personal experience. How to read time course of some values and tumor marker doubling time].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1991 Apr; 18(4):665-70. PubMed ID: 2012408
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
15. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of liver metastasis of colorectal cancer following hepatic arterial infusion with degradable starch microspheres and adriamycin, mitomycin C as seen in changes in CEA at early stage of therapy].
Takeuchi I; Ishida H; Hashimoto D; Mastumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1686-8. PubMed ID: 14619494
[TBL] [Abstract][Full Text] [Related]
17. Prediction of nodal metastasis and prognosis in breast cancer: a neural model.
Naguib RN; Adams AE; Horne CH; Angus B; Smith AF; Sherbet GV; Lennard TW
Anticancer Res; 1997; 17(4A):2735-41. PubMed ID: 9252707
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
[TBL] [Abstract][Full Text] [Related]
19. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
Takahashi Y; Mai M
Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of serum CA 125 values in patients with gastric cancers--especially correlation with peritonitis carcinomatosa].
Takahashi Y; Suga T; Mai M
Gan To Kagaku Ryoho; 1992 Jul; 19(7):975-9. PubMed ID: 1626954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
